Formulation and Quality – Biomolecular
2019 PharmSci 360
Biotechnologically produced medicines are an important class of therapeutics. Since the 1980s, there are more and more approved biotechnologically-produced medicines. For systemic use, these products require to be administered parenteralls. This talk aims to elaborate on the history of formulation of biologics, current challenges and hot topics when developing formulations of biologics, and some outlook on potential future challenges annd opportuniites, also for novel protein formats, oligonucleotides and cell therapy products.